{"result": {"id": "chatcmpl-193", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"Angiogenesis in Vascular Diseases\",\n    \"summary\": \"This report analyzes the interconnectedness of entities within the field of angiogenesis, focusing on its role in vascular diseases and treatment strategies. The community's core revolves around understanding how angiogenesis contributes to disease development and exploring potential therapeutic interventions. Key insights include the significant impact of VEGF inhibitors, the crucial role of microRNAs in regulating gene expression, and the importance of long noncoding RNAs as competing endogenous RNAs.\",\n    \"rating\": 8,\n    \"rating_explanation\": \"The community's focus on angiogenesis in vascular diseases, its potential for therapeutic interventions, and the significant impact of key entities like VEGF inhibitors and microRNAs make it a highly impactful area of research. \",\n    \"findings\": [\n        {\n            \"summary\": \"VEGF Inhibitors: A Promising Therapeutic Approach\",\n            \"explanation\": \"Vascular endothelial growth factor (VEGF) inhibitors have emerged as a crucial therapeutic strategy for managing angiogenesis-related vascular diseases. These drugs effectively target VEGF, a key signaling molecule involved in the formation and growth of new blood vessels. The report highlights the significant role of Bevacizumab, a well-established VEGF inhibitor, in treating various vascular diseases such as macular degeneration and cancer.  The success of Bevacizumab underscores the potential of targeting angiogenesis for therapeutic interventions.\"\n        },\n        {\n            \"summary\": \"MicroRNAs: Regulating Angiogenesis through Gene Expression\",\n            \"explanation\": \"MicroRNAs (miRNAs) are small non-coding RNA molecules that play a critical role in regulating gene expression. The report explores how miRNAs, specifically miR-126 and miR-340-5p, influence angiogenesis by targeting specific genes involved in the process.  miR-126 has been shown to promote angiogenesis, while miR-340-5p is associated with inhibiting angiogenesis. This highlights the potential of miRNA-based therapies for modulating angiogenesis.\"\n        },\n        {\n            \"summary\": \"Long Noncoding RNAs: Competing Endogenous RNAs\",\n            \"explanation\": \"Long noncoding RNAs (lncRNAs) are a class of RNA molecules that do not code for proteins but play crucial roles in gene regulation. The report explores the function of lncRNAs as competing endogenous RNAs (ceRNAs).  These RNAs can bind to microRNAs, thereby modulating their activity and influencing gene expression. This mechanism highlights the potential of lncRNAs as therapeutic targets for angiogenesis-related diseases.\"\n        },\n        {\n            \"summary\": \"Impact of Angiogenesis on Vascular Diseases\",\n            \"explanation\": \"Angiogenesis is a complex biological process that plays a significant role in various vascular diseases, including cancer, cardiovascular disease, and macular degeneration. The report explores the mechanisms by which angiogenesis contributes to these diseases.  For example, it discusses how VEGF-mediated angiogenesis promotes tumor growth and metastasis in cancer. Understanding the role of angiogenesis in these diseases is crucial for developing effective therapeutic strategies.\"\n        },\n        {\n            \"summary\": \"Challenges and Future Directions\",\n            \"explanation\": \"Despite significant progress in understanding angiogenesis, challenges remain in developing targeted therapies.  The report highlights the need for further research to develop more precise and effective treatments. This includes exploring novel targets for angiogenesis inhibition, optimizing drug delivery systems, and addressing potential side effects.\"\n        }\n    ]\n} \n\n\n\n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743091088, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 703, "prompt_tokens": 2048, "total_tokens": 2751, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n709,VEGF-A,\"**VEGF-A**, also known as **Vascular Endothelial Growth Factor A**, is a protein that plays a critical role in **angiogenesis**.  It is a signaling molecule and growth factor that promotes the formation of new blood vessels. VEGF-A is involved in both normal physiological angiogenesis, such as wound healing and tissue repair, and tumor angiogenesis, where it contributes to the development and spread of tumors.  Stimulation of VEGF-A leads to an upregulation of its own expression, further promoting angiogenesis. \n\",11\n1171,TUBE FORMATION,,8\n1026,VEGFR2,\"## VEGFR2: A Comprehensive Summary\n\n**VEGFR2**, also known as **Vascular Endothelial Growth Factor Receptor 2**, is a protein that plays a crucial role in various biological processes, particularly angiogenesis.  It acts as a receptor for vascular endothelial growth factor (VEGF) family members, including VEGF-A, and VEGFC. This binding triggers downstream signaling pathways, leading to the proliferation, migration, and survival of endothelial cells, which are essential components of blood vessels. \n\nVEGFR2 is involved in **tumor growth and progression**, making it a target for cancer treatment.  It's also implicated in **cell signaling** and **vascular development**.  Research has shown its involvement in angiogenesis, the formation of new blood vessels, which is crucial for tissue repair and tumor growth.  \n\n\n**Key Points:**\n\n* **Function:** Receptor tyrosine kinase involved in angiogenesis\n* **Target:** VEGF-A (Vascular Endothelial Growth Factor A) and VEGFC \n* **Role:** Promotes endothelial cell proliferation, migration, and survival\n* **Clinical Relevance:** Potential target for cancer treatment due to its role in tumor growth. \n\n\n\",15\n1069,P130CAS,\"The **P130CAS** protein is a significant player in both tumor growth and endothelial cell death.  It plays a role in promoting tumor development by contributing to the process of tumor growth, but it also has a direct impact on endothelial cells, leading to their demise. \n\n\nLet me know if you'd like me to analyze more data! \n\",3\n3579,DIXDC1,\"The **DIXDC1** protein is a crucial player in both angiogenesis and vasculature development.  It plays a role in the formation of new blood vessels, which are essential for proper tissue growth and repair. \n\",3\n1070,AUTOPHAGOSOMES,Cellular structures involved in autophagy,2\n4750,GXNT,\"The **GXNT** entity is a compound with pro-angiogenic effects, meaning it promotes blood vessel growth. It also acts as a substance that blocks the pro-angiogenic effects of VEGF-A, a protein involved in angiogenesis.  Furthermore, GXNT is a botanical drug known as Guanxinning Tablet (GXNT). \n\",2\n4759,SALB/FA,Treatment that restored G1-S cell cycle progression,2\n4760,VEGF-B,Growth factor that promotes angiogenesis,2\n4761,PGFB,Growth factor that promotes angiogenesis,2\n1071,TNKS1BP1,Protein that interacts with VEGFR2 and p130cas,1\n1765,VEGFR3,Protein involved in angiogenesis,1\n3778,P<SUB>1</SUB>,The P<sub>1</sub> coding sequence was used to activate VEGFR2 phosphorylation,1\n3040,CD146,Protein involved in retinal angiogenesis,1\n5155,BROUSSONIN A,\"Broussonin A is a chemical compound, specifically isolated from the plant *Broussonetia kazinoki*. It is known for its ability to inhibit angiogenesis, which is the formation of new blood vessels. \n\",5\n5156,BROUSSONIN B,\"The **BROUSSONIN B** is a chemical compound. It is also a chemical compound that inhibits angiogenesis, meaning it prevents the formation of new blood vessels.  This compound was isolated from the plant *Broussonetia kazinoki*. \n\",5\n1764,VEGFR1,\"The **VEGFR1** protein is a crucial player in tumor growth and angiogenesis. It's a gene that is expressed in animal models of human tumors, specifically those treated with the drug  hTPC. This protein is also known to be involved in the process of angiogenesis, which refers to the formation of new blood vessels. \n\",4\n2091,MTA1‑KO MSS31 CELLS,,1\n5181,LINC02802,\"The gene **LINC02802** functions as a long non-coding RNA (lncRNA) and acts as a competing endogenous RNA (ceRNA).  It has been identified as a potential regulator of endothelial cell sprouting. \n\",5\n5182,MAML3,\"The **MAML3** protein plays a role in regulating **angiogenesis**, the formation of new blood vessels.  It is also influenced by the gene **LINC02802**, which regulates its expression. \n\",3\n1265,VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF),A protein involved in angiogenesis,3\n1067,BEVACIZUMAB,\"**Bevacizumab** is a drug used in anti-angiogenic therapies, specifically targeting the VEGF pathway. It is used in the treatment of various cancers and certain eye diseases, including vascular leakage. Bevacizumab is an anti-cancer drug that helps to treat corneal neovascularization.  It has been studied for its potential use in treating cancer and other conditions. \n\",4\n30,MSC,\"The **MSC** (Multipotent Stromal Cell) is a type of stem cell used in medicine and research.  It's known for its potential in cell therapy, particularly in wound healing applications. MSCs are multipotent stromal cells, meaning they can differentiate into various cell types. They are also referred to as Mesenchymal Stem Cells (MSCs).  Research on MSCs focuses on their ability to regenerate tissues and repair damaged areas of the musculoskeletal system. \n\",4\n2734,MIR-340-5P,MicroRNA involved in the therapeutic effect of MSCs on corneal neovascularization,3\n5159,ENDOTHELIAL CELL MIGRATION,\"\nMovement of endothelial cells\",2\n5160,MICROVESSEL FORMATION,\"\nFormation of small blood vessels)<|COMPLETE|> Please provide me with the following information so I can help you with this task:1. **The previous extraction results:**  Share the list of entities and relationships that were extracted in your last attempt. This will give me context about what types you're looking for. 2. **The text you want to extract entities from:** Paste the text you want to analyze. Once I have this information, I can help you identify and extract relevant entities based on your previously defined types.\",2\n5183,MIR-486-5P,MicroRNA that competes with LINC02802 for binding to MAML3,2\n4776,VEGF INHIBITORS,\"**VEGF inhibitors** are a class of drugs used in the treatment of **myopic choroidal neovascularization (mCNV)**.  They are also employed in managing **mCNV**, a condition where abnormal blood vessel growth occurs in the eye's macula, leading to vision loss. \n\",2\n320,MCNV,\"**MCNV (myopic patients with central nervous system visual impairment)** refers to a condition affecting the eye, often characterized by damage to a part of the brain.  This condition can be particularly prevalent in myopic patients, where vision is impaired due to nearsightedness. \n\",4\n5180,VEGETA-A,Growth factor that stimulates endothelial cell sprouting,1\n1452,ANGIOGENIC MEDIATORS,These are the targets of research for new treatments,1\n2296,MMP2,,2\n1458,INVASION,\"The **INVASION** refers to the process of entering or penetrating a barrier, often involving organisms. This can involve movement into a new area, as well as the evaluation of invasion and angiogenesis. \n\",3\n3581,WNT SIGNALING,Signaling pathway that regulates angiogenesis,2\n4290,MIR-126,A type of RNA that is used to study the effects of MSCs on CLI,1\n4782,TREATMENT OUTCOMES,,1\n4783,TREATMENT FREQUENCY,,1\n4784,VISIT FREQUENCY,,1\n5177,LONG-NONCODING RNA,RNA molecules involved in regulating angiogenesis,3\n5179,CE-RNA,,2\n5178,MICRO-RNA,RNA molecules involved in regulating angiogenesis,3\n2159,TUMORAL ANGIOGENESIS,A process involved in cancer cell growth and spread,1\n2160,FRANCE,Country where VEGF inhibitors were first approved,1\n2735,EMP2,Epithelial membrane protein 2 is a gene that may be involved in angiogenesis,1\n2733,PROX1,A gene involved in angiogenesis,1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\n2200,VEGF-A,ENDOTHELIAL CELLS,\"VEGF-A activates endothelial cells, which are involved in blood vessel formation\",50\n374,VEGFA,TUBE FORMATION,VEGFA promotes tube formation,31\n324,VEGFR2,P130CAS,\"VEGFR2 fragments internalize into the nucleus and autophagosomes, initiating endothelial cell death\",18\n1429,DIXDC1,VEGFR2,\"VEGFR2 is stabilized by the interaction with DIXDC1\nDIXDC1 interacts with VEGFR2 to stabilize it via direct interaction\",18\n326,VEGFR2,AUTOPHAGOSOMES,VEGFR2 fragments internalize into autophagosomes to initiate endothelial cell death,17\n1978,GXNT,VEGFR2,GXNT treatment increased VEGFR2 expression,17\n1979,SALB/FA,VEGFR2,SalB/FA treatment increased VEGFR2 expression,17\n1982,VEGFR2,VEGF-B,VEGFR2 increased expression of VEGF-B,17\n1983,VEGFR2,PGFB,VEGFR2 increased expression of PGFB,17\n325,VEGFR2,TNKS1BP1,VEGFR2 and TNKS1BP1 interact to initiate endothelial cell death,16\n1550,VEGFR3,VEGFR2,VEGFR3 activates VEGFR2,16\n1554,P<SUB>1</SUB>,VEGFR2,The P<sub>1</sub> coding sequence activates VEGFR2 phosphorylation,16\n1599,VEGFR2,CD146,CD146 is involved in the development of retinal neovascularization via VEGFR2 pathway,16\n2176,BROUSSONIN A,VEGF-A,Broussonin A inhibits VEGF-A-stimulated angiogenic responses,16\n2181,BROUSSONIN B,VEGF-A,Broussonin B inhibits VEGF-A-stimulated angiogenic responses,16\n1984,VEGFR1,VEGF-A,VEGF-A increased expression of VEGFR1,15\n757,MTA1‑KO MSS31 CELLS,TUBE FORMATION,MTA1-knockout endothelial cells show reduced tube formation,9\n2209,LINC02802,MAML3,\"LINC02802 acts as a ceRNA, regulating MAML3 expression\",8\n795,VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF),BEVACIZUMAB,Bevacizumab targets the VEGF pathway,7\n1053,MSC,MIR-340-5P,MSCs use miR-340-5p to mediate their therapeutic effect on CNV,7\n2177,BROUSSONIN A,ENDOTHELIAL CELL MIGRATION,Broussonin A inhibits endothelial cell migration,7\n2180,BROUSSONIN A,MICROVESSEL FORMATION,Broussonin A inhibits microvessel formation,7\n2210,LINC02802,MIR-486-5P,\"LINC02802 acts as a ceRNA, regulating miR-486-5p expression\nLINC02802 competes with miR-486-5p for binding to MAML3\",7\n2001,VEGF INHIBITORS,MCNV,VEGF inhibitors are used to treat mCNV,6\n2208,VEGETA-A,LINC02802,LINC02802 expression was upregulated after VEGF-A stimulation,6\n327,P130CAS,AUTOPHAGOSOMES,p130cas interacts with autophagosomes to initiate endothelial cell death,5\n487,BEVACIZUMAB,ANGIOGENIC MEDIATORS,Bevacizumab is a potential therapeutic target for angiogenic mediators,5\n894,MMP2,INVASION,MMP2 downregulation indicates inhibition of invasion,5\n1430,DIXDC1,WNT SIGNALING,Wnt signaling potentiates the complex formation and stability of VEGFR2,5\n1798,MSC,MIR-126,MSCs treated with miR-126 showed better results,5\n2003,MCNV,TREATMENT OUTCOMES,mCNV has favorable treatment outcomes,5\n2004,MCNV,TREATMENT FREQUENCY,mCNV requires frequent treatment,5\n2005,MCNV,VISIT FREQUENCY,mCNV requires frequent visits for treatment,5\n2205,LONG-NONCODING RNA,CE-RNA,Long noncoding RNAs can act as competing endogenous RNAs to regulate gene expression,5\n2206,MICRO-RNA,CE-RNA,MicroRNAs can act as competing endogenous RNAs to regulate gene expression,5\n2213,MAML3,MIR-486-5P,MAML3 is regulated by miR-486-5p,5\n794,TUMORAL ANGIOGENESIS,VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF),Tumoral angiogenesis is a mechanism that involves VEGF growth factor,4\n796,VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF),FRANCE,France approved VEGF inhibitors in 2005,4\n1055,MIR-340-5P,EMP2,miR-340-5p represses EMP2 expression,4\n1056,MIR-340-5P,PROX1,miR-340-5p represses PROX1 expression,4\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 2000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_23bf05dca6d6fd3876934c3638523a85b8cd552859abc7356a10f8bfe4eb364d_v2"}